# Blue Light Cystoscopy With Cysview® Registry

> **NCT02660645** · — · RECRUITING · sponsor: **Photocure** · enrollment: 4400 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Hexaminolevulinate hydrochloride (HCL)
- **DEVICE:** Karl Storz D-Light C Photodynamic Diagnostic (PDD) system

## Key facts

- **NCT ID:** NCT02660645
- **Lead sponsor:** Photocure
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2014-04
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 4400 (ESTIMATED)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02660645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02660645, "Blue Light Cystoscopy With Cysview® Registry". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02660645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*